Dopamine trasporter reversal as a pathogenic mechanism for L-dopa induced dyskinesia
L-dopa remains the most effective drug for improving motor symptoms of Parkinson's disease (PD). However, following long-term chronic treatment, the therapeutic effects of L-dopa are often accompanied by debilitating peak-dose dyskinesia. The mechanisms underlying L-dopa induced dyskinesia r...
Main Author: | Cheng, Christina |
---|---|
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/16493 |
Similar Items
-
Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID)
by: Kai Yang, et al.
Published: (2021-03-01) -
Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
by: Cristoforo Comi, et al.
Published: (2017-01-01) -
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
by: Kathryn Lanza, et al.
Published: (2021-03-01) -
Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia
by: Joanna García, et al.
Published: (2011-09-01) -
Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
by: Fabbrini A, et al.
Published: (2021-04-01)